Stocks
Teva Pharmaceutical Industries (TEVA) Debt/EBITDA US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| Debt/EBITDA | 19.8 | -11.6 | 4.83 | -21.5 | 3.91 | 7.88 | |||
| Changes by years, y/y, % | +131% | -158% | -142% | -544% | -118% | -14.6% | |||
Teva Pharmaceutical Industries. Debt/EBITDA
Teva Pharmaceutical Industries. Debt/EBITDA, changes, %
Teva Pharmaceutical Industries (TEVA) Debt/EBITDA US GAAP (quarter values) |
||||||||
| 2023Q4 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| Debt/EBITDA | 4.71 | 3.89 | 4.73 | 5.83 | 7.88 | 7.88 | ||
| Changes by years, y/y, % | +3% | -15% | -2% | +22% | +70% | |||
| Changes by quarters, q/q, % | +1% | -17% | +22% | +23% | +35% | |||
